These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 7432401)

  • 21. Device-Associated Menstrual Toxic Shock Syndrome.
    Schlievert PM; Davis CC
    Clin Microbiol Rev; 2020 Jun; 33(3):. PubMed ID: 32461307
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Menstrual TSS remains a dangerous threat.
    Schlievert PM
    EClinicalMedicine; 2020 Apr; 21():100316. PubMed ID: 32382715
    [No Abstract]   [Full Text] [Related]  

  • 23. Association of characteristics of tampon use with menstrual toxic shock syndrome in France.
    Billon A; Gustin MP; Tristan A; Bénet T; Berthiller J; Gustave CA; Vanhems P; Lina G
    EClinicalMedicine; 2020 Apr; 21():100308. PubMed ID: 32382713
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Case report of an unusual presentation of Staphylococcus aureus induced toxic shock syndrome/hyperimmunoglobulinemia E syndrome.
    Jacob HS; Vercellotti GM; Leung DYM; Schlievert PM
    Medicine (Baltimore); 2020 Apr; 99(15):e19746. PubMed ID: 32282735
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of non-absorbent intravaginal menstrual/contraceptive products on Staphylococcus aureus and production of the superantigen TSST-1.
    Schlievert PM
    Eur J Clin Microbiol Infect Dis; 2020 Jan; 39(1):31-38. PubMed ID: 31853743
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of a vaccine against Staphylococcus aureus invasive infections: Evidence based on human immunity, genetics and bacterial evasion mechanisms.
    Miller LS; Fowler VG; Shukla SK; Rose WE; Proctor RA
    FEMS Microbiol Rev; 2020 Jan; 44(1):123-153. PubMed ID: 31841134
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Staphylococcal Superantigens Stimulate Epithelial Cells through CD40 To Produce Chemokines.
    Schlievert PM; Cahill MP; Hostager BS; Brosnahan AJ; Klingelhutz AJ; Gourronc FA; Bishop GA; Leung DYM
    mBio; 2019 Mar; 10(2):. PubMed ID: 30890614
    [TBL] [Abstract][Full Text] [Related]  

  • 28.
    Tam K; Torres VJ
    Microbiol Spectr; 2019 Mar; 7(2):. PubMed ID: 30873936
    [No Abstract]   [Full Text] [Related]  

  • 29. Contribution of toxic shock syndrome toxin-1 to systemic inflammation investigated by a mouse model of cervicovaginal infection with Staphylococcus aureus.
    Asano K; Narita K; Hirose S; Nakane A
    Med Microbiol Immunol; 2018 Nov; 207(5-6):297-306. PubMed ID: 29980843
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Role of Antibiotics in Modulating Virulence in Staphylococcus aureus.
    Hodille E; Rose W; Diep BA; Goutelle S; Lina G; Dumitrescu O
    Clin Microbiol Rev; 2017 Oct; 30(4):887-917. PubMed ID: 28724662
    [No Abstract]   [Full Text] [Related]  

  • 31. Safety and Immunogenicity of a Parenterally Administered, Structure-Based Rationally Modified Recombinant Staphylococcal Enterotoxin B Protein Vaccine, STEBVax.
    Chen WH; Pasetti MF; Adhikari RP; Baughman H; Douglas R; El-Khorazaty J; Greenberg N; Holtsberg FW; Liao GC; Reymann MK; Wang X; Warfield KL; Aman MJ
    Clin Vaccine Immunol; 2016 Dec; 23(12):918-925. PubMed ID: 27707765
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The SaeRS Two-Component System Is a Direct and Dominant Transcriptional Activator of Toxic Shock Syndrome Toxin 1 in Staphylococcus aureus.
    Baroja ML; Herfst CA; Kasper KJ; Xu SX; Gillett DA; Li J; Reid G; McCormick JK
    J Bacteriol; 2016 Oct; 198(19):2732-42. PubMed ID: 27457715
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intrauterine device infection causing concomitant streptococcal toxic shock syndrome and pelvic abscess with Actinomyces odontolyticus bacteraemia.
    Wu CM; Noska A
    BMJ Case Rep; 2016 Mar; 2016():. PubMed ID: 26965406
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunomodulation and Disease Tolerance to Staphylococcus aureus.
    Li Z; Peres AG; Damian AC; Madrenas J
    Pathogens; 2015 Nov; 4(4):793-815. PubMed ID: 26580658
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Staphylococcal toxic shock syndrome: superantigen-mediated enhancement of endotoxin shock and adaptive immune suppression.
    Kulhankova K; King J; Salgado-Pabón W
    Immunol Res; 2014 Aug; 59(1-3):182-7. PubMed ID: 24816557
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel antimicrobial peptides that inhibit gram positive bacterial exotoxin synthesis.
    Merriman JA; Nemeth KA; Schlievert PM
    PLoS One; 2014; 9(4):e95661. PubMed ID: 24748386
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The contribution of group A streptococcal virulence determinants to the pathogenesis of sepsis.
    Reglinski M; Sriskandan S
    Virulence; 2014 Jan; 5(1):127-36. PubMed ID: 24157731
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Menaquinone analogs inhibit growth of bacterial pathogens.
    Schlievert PM; Merriman JA; Salgado-Pabón W; Mueller EA; Spaulding AR; Vu BG; Chuang-Smith ON; Kohler PL; Kirby JR
    Antimicrob Agents Chemother; 2013 Nov; 57(11):5432-7. PubMed ID: 23959313
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Staphylococcal and streptococcal superantigen exotoxins.
    Spaulding AR; Salgado-Pabón W; Kohler PL; Horswill AR; Leung DY; Schlievert PM
    Clin Microbiol Rev; 2013 Jul; 26(3):422-47. PubMed ID: 23824366
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epithelial proinflammatory response and curcumin-mediated protection from staphylococcal toxic shock syndrome toxin-1.
    Schaefers MM; Breshears LM; Anderson MJ; Lin YC; Grill AE; Panyam J; Southern PJ; Schlievert PM; Peterson ML
    PLoS One; 2012; 7(3):e32813. PubMed ID: 22431984
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.